Marianne Mancini
Chief Operating Officer
COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Viking Therapeutics, Inc. (VKTX) | Chief Operating Officer | $540,000 | $5,162,872 |
| 2024 | Viking Therapeutics, Inc. (VKTX) | Chief | $490,000 | $4,703,394 |
| 2023 | Viking Therapeutics, Inc. (VKTX) | Chief | $465,000 | $3,510,957 |
| 2022 | Viking Therapeutics, Inc. (VKTX) | Chief | $446,000 | $2,052,044 |
| 2021 | Viking Therapeutics, Inc. (VKTX) | Chief Operating Officer | $405,000 | $1,507,624 |
Earnings-call appearances
No earnings-call appearances recorded yet.